Gadolinium-enhanced T1-weighted volumetric interpolated breath-hold exam (VIBE) is best for detecting prostate cancer metastases, according to a study published in the 

Researchers from Canada performed a prospective study to compare the diagnostic value of various MRI sequences used for whole-body (WB) 18F-fluorocholine (FCH) PET/MRI staging of patients with high-risk 

. The study included 58 patients with untreated high-risk prostate cancer. Ten patients underwent integrated WB FCH PET/MRI; 48 underwent FCH PET/CT and WB MRI. The researchers recorded metastatic sites and used histopathologic findings or clinical and imaging follow-up (or both) for standard of reference.

The results showed the gadolinium-enhanced T1-weighted volumetric interpolated breath-hold exam (VIBE) was the best of the four sequences:

Conspicuity of metastases on gadolinium-enhanced T1-weighted VIBE and WB DWI sequences was higher than that on Dixon T1-weighted sequences.

The researchers concluded that metastases from prostate cancer are best detected at DWI or gadolinium-enhanced T1-weighted VIBE sequences. The most time-efficient sequence with the highest lesion detection rate and conspicuity is gadolinium-enhanced T1-weighted VIBE.

Oncology CT

 MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

The imaging process provides the most time-efficient sequence with the highest lesion detection rate and conspicuity.

Dixon T1-weighted	1 min. 25 sec.	88.3% (68/77)	62.3% (48/77)
Turbo inversion recovery magnitude	15 min. 7 sec.	94.8% (73/77)	88.3% (68/77)
WB DWI	16 min. 33 sec.	95.2% (40/42)	90.5% (38/42)
Gadolinium-enhanced T1-weighted VIBE	1 min. 28 sec.	97.4% (75/77)	92.2% (71/77)

What Method Is Best for Detecting Prostate Cancer Metastases?